Eswatini
Jan 8, 2023
A Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Pre-Exposure Prophylaxis in Cisgender Women at High Risk for HIV-1 Infection. ICAP...
Dec 28, 2022
Link4Health was a cluster-randomized, controlled trial that evaluated the effectiveness of a combination intervention strategy versus the standard of care on the primary outcome of linkage to care within one month and retention in care at 12 months following HIV...
Dec 27, 2022
The Link4Health study supplement evaluated the feasibility and acceptability of implementing cardiovascular disease risk factor (CVDRF) screening and management among HIV-positive adults enrolled in care at the Raleigh Fitkin Memorial Hospital ART clinic. It also...
Dec 20, 2022
The MTCT-Plus Initiative, the world’s first multi-country HIV treatment program, aimed to demonstrate to a disbelieving world that it was possible to provide care and antiretroviral (ARV) treatment in resource-limited settings, using programs to prevent...
Dec 12, 2022
PHIA is a multi-country initiative led by ICAP, the U.S. Centers for Disease Control and Prevention (CDC), and ministries of health in PEPFAR-supported countries. Each survey offers household-based HIV counseling and testing conducted by trained survey staff, with...
